Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Iron Drugs Revenue 1.4 Market Analysis by Type 1.4.1 Global Iron Drugs Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Oral Drug 1.4.3 IV Drug 1.5 Market by Application 1.5.1 Global Iron Drugs Market Share by Application: 2020 VS 2026 1.5.2 Hospital 1.5.3 Drugstore 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Iron Drugs Market Perspective (2015-2026) 2.2 Iron Drugs Growth Trends by Regions 2.2.1 Iron Drugs Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Iron Drugs Historic Market Share by Regions (2015-2020) 2.2.3 Iron Drugs Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Iron Drugs Market Growth Strategy 2.3.6 Primary Interviews with Key Iron Drugs Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Iron Drugs Players by Market Size 3.1.1 Global Top Iron Drugs Players by Revenue (2015-2020) 3.1.2 Global Iron Drugs Revenue Market Share by Players (2015-2020) 3.1.3 Global Iron Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Iron Drugs Market Concentration Ratio 3.2.1 Global Iron Drugs Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Iron Drugs Revenue in 2019 3.3 Iron Drugs Key Players Head office and Area Served 3.4 Key Players Iron Drugs Product Solution and Service 3.5 Date of Enter into Iron Drugs Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Iron Drugs Historic Market Size by Type (2015-2020) 4.2 Global Iron Drugs Forecasted Market Size by Type (2021-2026) 5 Iron Drugs Breakdown Data by Application (2015-2026) 5.1 Global Iron Drugs Market Size by Application (2015-2020) 5.2 Global Iron Drugs Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Iron Drugs Market Size (2015-2020) 6.2 Iron Drugs Key Players in North America (2019-2020) 6.3 North America Iron Drugs Market Size by Type (2015-2020) 6.4 North America Iron Drugs Market Size by Application (2015-2020) 7 Europe 7.1 Europe Iron Drugs Market Size (2015-2020) 7.2 Iron Drugs Key Players in Europe (2019-2020) 7.3 Europe Iron Drugs Market Size by Type (2015-2020) 7.4 Europe Iron Drugs Market Size by Application (2015-2020) 8 China 8.1 China Iron Drugs Market Size (2015-2020) 8.2 Iron Drugs Key Players in China (2019-2020) 8.3 China Iron Drugs Market Size by Type (2015-2020) 8.4 China Iron Drugs Market Size by Application (2015-2020) 9 Japan 9.1 Japan Iron Drugs Market Size (2015-2020) 9.2 Iron Drugs Key Players in Japan (2019-2020) 9.3 Japan Iron Drugs Market Size by Type (2015-2020) 9.4 Japan Iron Drugs Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Iron Drugs Market Size (2015-2020) 10.2 Iron Drugs Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Iron Drugs Market Size by Type (2015-2020) 10.4 Southeast Asia Iron Drugs Market Size by Application (2015-2020) 11 India 11.1 India Iron Drugs Market Size (2015-2020) 11.2 Iron Drugs Key Players in India (2019-2020) 11.3 India Iron Drugs Market Size by Type (2015-2020) 11.4 India Iron Drugs Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Iron Drugs Market Size (2015-2020) 12.2 Iron Drugs Key Players in Central & South America (2019-2020) 12.3 Central & South America Iron Drugs Market Size by Type (2015-2020) 12.4 Central & South America Iron Drugs Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Allergan 13.1.1 Allergan Company Details 13.1.2 Allergan Business Overview and Its Total Revenue 13.1.3 Allergan Iron Drugs Introduction 13.1.4 Allergan Revenue in Iron Drugs Business (2015-2020)) 13.1.5 Allergan Recent Development 13.2 AMAG Pharmaceuticals 13.2.1 AMAG Pharmaceuticals Company Details 13.2.2 AMAG Pharmaceuticals Business Overview and Its Total Revenue 13.2.3 AMAG Pharmaceuticals Iron Drugs Introduction 13.2.4 AMAG Pharmaceuticals Revenue in Iron Drugs Business (2015-2020) 13.2.5 AMAG Pharmaceuticals Recent Development 13.3 Daiichi Sankyo 13.3.1 Daiichi Sankyo Company Details 13.3.2 Daiichi Sankyo Business Overview and Its Total Revenue 13.3.3 Daiichi Sankyo Iron Drugs Introduction 13.3.4 Daiichi Sankyo Revenue in Iron Drugs Business (2015-2020) 13.3.5 Daiichi Sankyo Recent Development 13.4 Pharmacosmos 13.4.1 Pharmacosmos Company Details 13.4.2 Pharmacosmos Business Overview and Its Total Revenue 13.4.3 Pharmacosmos Iron Drugs Introduction 13.4.4 Pharmacosmos Revenue in Iron Drugs Business (2015-2020) 13.4.5 Pharmacosmos Recent Development 13.5 Vifor Pharma 13.5.1 Vifor Pharma Company Details 13.5.2 Vifor Pharma Business Overview and Its Total Revenue 13.5.3 Vifor Pharma Iron Drugs Introduction 13.5.4 Vifor Pharma Revenue in Iron Drugs Business (2015-2020) 13.5.5 Vifor Pharma Recent Development 13.6 Galenica 13.6.1 Galenica Company Details 13.6.2 Galenica Business Overview and Its Total Revenue 13.6.3 Galenica Iron Drugs Introduction 13.6.4 Galenica Revenue in Iron Drugs Business (2015-2020) 13.6.5 Galenica Recent Development 13.7 Nippon Shinyaku 13.7.1 Nippon Shinyaku Company Details 13.7.2 Nippon Shinyaku Business Overview and Its Total Revenue 13.7.3 Nippon Shinyaku Iron Drugs Introduction 13.7.4 Nippon Shinyaku Revenue in Iron Drugs Business (2015-2020) 13.7.5 Nippon Shinyaku Recent Development 13.8 Sanofi 13.8.1 Sanofi Company Details 13.8.2 Sanofi Business Overview and Its Total Revenue 13.8.3 Sanofi Iron Drugs Introduction 13.8.4 Sanofi Revenue in Iron Drugs Business (2015-2020) 13.8.5 Sanofi Recent Development 13.9 Wanbang Biopharmaceutical 13.9.1 Wanbang Biopharmaceutical Company Details 13.9.2 Wanbang Biopharmaceutical Business Overview and Its Total Revenue 13.9.3 Wanbang Biopharmaceutical Iron Drugs Introduction 13.9.4 Wanbang Biopharmaceutical Revenue in Iron Drugs Business (2015-2020) 13.9.5 Wanbang Biopharmaceutical Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Iron Drugs Key Market Segments Table 2. Key Players Covered: Ranking by Iron Drugs Revenue Table 3. Ranking of Global Top Iron Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Iron Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Oral Drug Table 6. Key Players of IV Drug Table 7. Global Iron Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 8. Global Iron Drugs Market Size by Regions (US$ Million): 2020 VS 2026 Table 9. Global Iron Drugs Market Size by Regions (2015-2020) (US$ Million) Table 10. Global Iron Drugs Market Share by Regions (2015-2020) Table 11. Global Iron Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 12. Global Iron Drugs Market Share by Regions (2021-2026) Table 13. Market Top Trends Table 14. Key Drivers: Impact Analysis Table 15. Key Challenges Table 16. Iron Drugs Market Growth Strategy Table 17. Main Points Interviewed from Key Iron Drugs Players Table 18. Global Iron Drugs Revenue by Players (2015-2020) (Million US$) Table 19. Global Iron Drugs Market Share by Players (2015-2020) Table 20. Global Top Iron Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Iron Drugs as of 2019) Table 21. Global Iron Drugs by Players Market Concentration Ratio (CR5 and HHI) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Iron Drugs Product Solution and Service Table 24. Date of Enter into Iron Drugs Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Iron Drugs Market Size by Type (2015-2020) (Million US$) Table 27. Global Iron Drugs Market Size Share by Type (2015-2020) Table 28. Global Iron Drugs Revenue Market Share by Type (2021-2026) Table 29. Global Iron Drugs Market Size Share by Application (2015-2020) Table 30. Global Iron Drugs Market Size by Application (2015-2020) (Million US$) Table 31. Global Iron Drugs Market Size Share by Application (2021-2026) Table 32. North America Key Players Iron Drugs Revenue (2019-2020) (Million US$) Table 33. North America Key Players Iron Drugs Market Share (2019-2020) Table 34. North America Iron Drugs Market Size by Type (2015-2020) (Million US$) Table 35. North America Iron Drugs Market Share by Type (2015-2020) Table 36. North America Iron Drugs Market Size by Application (2015-2020) (Million US$) Table 37. North America Iron Drugs Market Share by Application (2015-2020) Table 38. Europe Key Players Iron Drugs Revenue (2019-2020) (Million US$) Table 39. Europe Key Players Iron Drugs Market Share (2019-2020) Table 40. Europe Iron Drugs Market Size by Type (2015-2020) (Million US$) Table 41. Europe Iron Drugs Market Share by Type (2015-2020) Table 42. Europe Iron Drugs Market Size by Application (2015-2020) (Million US$) Table 43. Europe Iron Drugs Market Share by Application (2015-2020) Table 44. China Key Players Iron Drugs Revenue (2019-2020) (Million US$) Table 45. China Key Players Iron Drugs Market Share (2019-2020) Table 46. China Iron Drugs Market Size by Type (2015-2020) (Million US$) Table 47. China Iron Drugs Market Share by Type (2015-2020) Table 48. China Iron Drugs Market Size by Application (2015-2020) (Million US$) Table 49. China Iron Drugs Market Share by Application (2015-2020) Table 50. Japan Key Players Iron Drugs Revenue (2019-2020) (Million US$) Table 51. Japan Key Players Iron Drugs Market Share (2019-2020) Table 52. Japan Iron Drugs Market Size by Type (2015-2020) (Million US$) Table 53. Japan Iron Drugs Market Share by Type (2015-2020) Table 54. Japan Iron Drugs Market Size by Application (2015-2020) (Million US$) Table 55. Japan Iron Drugs Market Share by Application (2015-2020) Table 56. Southeast Asia Key Players Iron Drugs Revenue (2019-2020) (Million US$) Table 57. Southeast Asia Key Players Iron Drugs Market Share (2019-2020) Table 58. Southeast Asia Iron Drugs Market Size by Type (2015-2020) (Million US$) Table 59. Southeast Asia Iron Drugs Market Share by Type (2015-2020) Table 60. Southeast Asia Iron Drugs Market Size by Application (2015-2020) (Million US$) Table 61. Southeast Asia Iron Drugs Market Share by Application (2015-2020) Table 62. India Key Players Iron Drugs Revenue (2019-2020) (Million US$) Table 63. India Key Players Iron Drugs Market Share (2019-2020) Table 64. India Iron Drugs Market Size by Type (2015-2020) (Million US$) Table 65. India Iron Drugs Market Share by Type (2015-2020) Table 66. India Iron Drugs Market Size by Application (2015-2020) (Million US$) Table 67. India Iron Drugs Market Share by Application (2015-2020) Table 68. Central & South America Key Players Iron Drugs Revenue (2019-2020) (Million US$) Table 69. Central & South America Key Players Iron Drugs Market Share (2019-2020) Table 70. Central & South America Iron Drugs Market Size by Type (2015-2020) (Million US$) Table 71. Central & South America Iron Drugs Market Share by Type (2015-2020) Table 72. Central & South America Iron Drugs Market Size by Application (2015-2020) (Million US$) Table 73. Central & South America Iron Drugs Market Share by Application (2015-2020) Table 74. Allergan Company Details Table 75. Allergan Business Overview Table 76. Allergan Product Table 77. Allergan Revenue in Iron Drugs Business (2015-2020) (Million US$) Table 78. Allergan Recent Development Table 79. AMAG Pharmaceuticals Company Details Table 80. AMAG Pharmaceuticals Business Overview Table 81. AMAG Pharmaceuticals Product Table 82. AMAG Pharmaceuticals Revenue in Iron Drugs Business (2015-2020) (Million US$) Table 83. AMAG Pharmaceuticals Recent Development Table 84. Daiichi Sankyo Company Details Table 85. Daiichi Sankyo Business Overview Table 86. Daiichi Sankyo Product Table 87. Daiichi Sankyo Revenue in Iron Drugs Business (2015-2020) (Million US$) Table 88. Daiichi Sankyo Recent Development Table 89. Pharmacosmos Company Details Table 90. Pharmacosmos Business Overview Table 91. Pharmacosmos Product Table 92. Pharmacosmos Revenue in Iron Drugs Business (2015-2020) (Million US$) Table 93. Pharmacosmos Recent Development Table 94. Vifor Pharma Company Details Table 95. Vifor Pharma Business Overview Table 96. Vifor Pharma Product Table 97. Vifor Pharma Revenue in Iron Drugs Business (2015-2020) (Million US$) Table 98. Vifor Pharma Recent Development Table 99. Galenica Company Details Table 100. Galenica Business Overview Table 101. Galenica Product Table 102. Galenica Revenue in Iron Drugs Business (2015-2020) (Million US$) Table 103. Galenica Recent Development Table 104. Nippon Shinyaku Company Details Table 105. Nippon Shinyaku Business Overview Table 106. Nippon Shinyaku Product Table 107. Nippon Shinyaku Revenue in Iron Drugs Business (2015-2020) (Million US$) Table 108. Nippon Shinyaku Recent Development Table 109. Sanofi Business Overview Table 110. Sanofi Product Table 111. Sanofi Company Details Table 112. Sanofi Revenue in Iron Drugs Business (2015-2020) (Million US$) Table 113. Sanofi Recent Development Table 114. Wanbang Biopharmaceutical Company Details Table 115. Wanbang Biopharmaceutical Business Overview Table 116. Wanbang Biopharmaceutical Product Table 117. Wanbang Biopharmaceutical Revenue in Iron Drugs Business (2015-2020) (Million US$) Table 118. Wanbang Biopharmaceutical Recent Development Table 119. Research Programs/Design for This Report Table 120. Key Data Information from Secondary Sources Table 121. Key Data Information from Primary Sources List of Figures Figure 1. Global Iron Drugs Market Share by Type: 2020 VS 2026 Figure 2. Oral Drug Features Figure 3. IV Drug Features Figure 4. Global Iron Drugs Market Share by Application: 2020 VS 2026 Figure 5. Hospital Case Studies Figure 6. Drugstore Case Studies Figure 7. Others Case Studies Figure 8. Iron Drugs Report Years Considered Figure 9. Global Iron Drugs Market Size YoY Growth 2015-2026 (US$ Million) Figure 10. Global Iron Drugs Market Share by Regions: 2020 VS 2026 Figure 11. Global Iron Drugs Market Share by Regions (2021-2026) Figure 12. Porter's Five Forces Analysis Figure 13. Global Iron Drugs Market Share by Players in 2019 Figure 14. Global Top Iron Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Iron Drugs as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Iron Drugs Revenue in 2019 Figure 16. North America Iron Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 17. Europe Iron Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 18. China Iron Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Japan Iron Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Southeast Asia Iron Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 21. India Iron Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Central & South America Iron Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Allergan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Allergan Revenue Growth Rate in Iron Drugs Business (2015-2020) Figure 25. AMAG Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. AMAG Pharmaceuticals Revenue Growth Rate in Iron Drugs Business (2015-2020) Figure 27. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Daiichi Sankyo Revenue Growth Rate in Iron Drugs Business (2015-2020) Figure 29. Pharmacosmos Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Pharmacosmos Revenue Growth Rate in Iron Drugs Business (2015-2020) Figure 31. Vifor Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Vifor Pharma Revenue Growth Rate in Iron Drugs Business (2015-2020) Figure 33. Galenica Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Galenica Revenue Growth Rate in Iron Drugs Business (2015-2020) Figure 35. Nippon Shinyaku Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Nippon Shinyaku Revenue Growth Rate in Iron Drugs Business (2015-2020) Figure 37. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Sanofi Revenue Growth Rate in Iron Drugs Business (2015-2020) Figure 39. Wanbang Biopharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Wanbang Biopharmaceutical Revenue Growth Rate in Iron Drugs Business (2015-2020) Figure 41. Bottom-up and Top-down Approaches for This Report Figure 42. Data Triangulation Figure 43. Key Executives Interviewed

Allergan AMAG Pharmaceuticals Daiichi Sankyo Pharmacosmos Vifor Pharma Galenica Nippon Shinyaku Sanofi Wanbang Biopharmaceutical